Kiniksa Pharmaceuticals International, plc
KNSA
43 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | Oct 20 9:49 PM | Patel Sanj K | Proposed Sale | 257,969 | $38.90 | $10.0M | — | View → |
| Oct 20, 2025 | Oct 20 9:48 PM | Megna Michael R | Proposed Sale | 50,490 | $38.88 | $2.0M | — | View → |
| Oct 14, 2025 | Oct 14 8:52 PM | Tessari Eben | Proposed Sale | 12,368 | $37.66 | $465.8K | — | View → |
| Sep 29, 2025 | Sep 29 9:24 PM | Tessari Eben | Proposed Sale | 42,000 | $38.33 | $1.6M | — | View → |
| Sep 15, 2025 | Sep 15 9:20 PM | Tessari Eben | Proposed Sale | 16,400 | $36.46 | $598.0K | — | View → |
| Sep 5, 2025 | Sep 5 8:39 PM | Tessari Eben | Proposed Sale | 13,389 | $35.66 | $477.5K | — | View → |
| Sep 4, 2025 | Sep 4 8:52 PM | Tessari Eben | Proposed Sale | 85,271 | $35.52 | $3.0M | — | View → |
| Sep 4, 2025 | Sep 4 8:51 PM | Moat Ross | Proposed Sale | 3,523 | $35.31 | $124.4K | — | View → |
| Sep 3, 2025 | Sep 3 8:56 PM | Tessari Eben | Proposed Sale | 15,091 | $35.50 | $535.8K | — | View → |
| Sep 3, 2025 | Sep 3 8:16 PM | Megna Michael R | Proposed Sale | 11,000 | $34.84 | $383.2K | — | View → |
| Aug 18, 2025 | Aug 18 9:13 PM | Tessari Eben | Proposed Sale | 16,200 | $33.77 | $547.1K | — | View → |
| Aug 14, 2025 | Aug 14 8:36 PM | Malley Thomas | Proposed Sale | 78,233 | $33.09 | $2.6M | — | View → |
| Aug 13, 2025 | Aug 13 8:24 PM | Malley Thomas | Proposed Sale | 50,129 | $33.32 | $1.7M | — | View → |
| Aug 12, 2025 | Aug 12 8:54 PM | Malley Thomas | Proposed Sale | 49,407 | $32.40 | $1.6M | — | View → |
| Aug 6, 2025 | Aug 6 9:37 PM | Paolini John F. | Proposed Sale | 29,325 | $32.55 | $954.5K | — | View → |
| Aug 5, 2025 | Aug 5 9:23 PM | Tessari Eben | Proposed Sale | 138,614 | $33.20 | $4.6M | — | View → |
| Aug 4, 2025 | Aug 4 8:09 PM | Ragosa Mark | Proposed Sale | 18,889 | $32.89 | $621.3K | — | View → |
| Aug 4, 2025 | Aug 4 8:09 PM | Megna Michael R | Proposed Sale | 17,000 | $32.35 | $549.9K | — | View → |
| Jul 30, 2025 | Jul 30 8:06 PM | KIMBERLY J. POPOVITS | Proposed Sale | 64,508 | $29.90 | $1.9M | — | View → |
| Jul 14, 2025 | Jul 14 9:04 PM | Tessari Eben | Proposed Sale | 18,900 | $28.72 | $542.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Apr 8 8:39 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 2,477 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:38 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 3,932 | — | 0(D) | View → |
| Apr 6, 2026 | Apr 8 8:34 PM | Barry D QuartDirector | Option Exercise | 6,901 | $14.33 | 26,336(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Option Exercise | 5,975 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Grant/Award | 58,100 | $48.13 | 16,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Grant/Award | 54,550 | $48.13 | 15,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 5,187 | — | 5,536(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 21,327 | — | 25,826(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 210,300 | $48.13 | 60,100(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 5,831 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Grant/Award | 46,850 | $48.13 | 13,400(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Grant/Award | 64,700 | $48.13 | 18,500(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 5,808 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Grant/Award | 25,550 | $48.13 | 7,300(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 7,564 | — | 7,931(D) | View → |
| Mar 9, 2026 | Mar 11 8:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 36,722 | $26.74 | 22,790(D) | View → |
| Mar 2, 2026 | Mar 4 9:40 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 40,000 | $10.36 | 58,424(D) | View → |
| Feb 12, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Option Exercise | 2,690 | $15.47 | 0(D) | View → |
| Feb 10, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Option Exercise | 110 | $15.47 | 2,690(D) | View → |
| Feb 9, 2026 | Feb 11 9:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 10,845 | $16.90 | 0(D) | View → |